Regulus Therapeutics Inc’s latest rating changes from various analysts
In a filing, Regulus Therapeutics Inc revealed its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.15 million. Then, CALSADA CRISPINA […]
Leerink Partners analysts initates an Outperform rating for Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.15 million. Then, CALSADA CRISPINA […]
Regulus Therapeutics Inc [RGLS] Investment Appeal on the Rise
Regulus Therapeutics Inc’s recently made public that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.16 million. Then, CALSADA CRISPINA […]
Negative sentiment towards RGLS reflected in surge in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Regulus Therapeutics Inc shares valued at $17,359 were sold by Hagan Joseph P on Jan 18 ’24. At $1.19 per share, Hagan Joseph P sold 14,580 shares. The insider’s holdings dropped to 57,112 shares […]
Leerink Partners analysts initates an Outperform rating for Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.15 million. Then, CALSADA CRISPINA […]
What Is Raising Regulus Therapeutics (RGLS) Stock This Morning?
Regulus Therapeutics Inc. (RGLS) shares gained 15.69% to $1.92 in Monday’s early session after reporting positive clinical trial results. A recent 5-day performance of 24.44% has been achieved by RGLS stock, which gained 5.00% last trading session to finish at $1.68. RGLS has shared what data? Today, Regulus Therapeutics (RGLS) announced that its Phase 1 […]
